KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Travere Therapeutics (TVTX) Intangibles (2016 - 2025)

Historic Intangibles for Travere Therapeutics (TVTX) over the last 13 years, with Q3 2025 value amounting to $109.4 million.

  • Travere Therapeutics' Intangibles rose 501.9% to $109.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $109.4 million, marking a year-over-year increase of 501.9%. This contributed to the annual value of $104.0 million for FY2024, which is 44.9% down from last year.
  • According to the latest figures from Q3 2025, Travere Therapeutics' Intangibles is $109.4 million, which was up 501.9% from $105.6 million recorded in Q2 2025.
  • Travere Therapeutics' 5-year Intangibles high stood at $162.9 million for Q1 2023, and its period low was $97.1 million during Q4 2022.
  • Moreover, its 5-year median value for Intangibles was $109.4 million (2025), whereas its average is $126.9 million.
  • Its Intangibles has fluctuated over the past 5 years, first skyrocketed by 759.22% in 2023, then tumbled by 3788.06% in 2024.
  • Over the past 5 years, Travere Therapeutics' Intangibles (Quarter) stood at $148.4 million in 2021, then plummeted by 34.6% to $97.1 million in 2022, then grew by 7.59% to $104.4 million in 2023, then dropped by 0.45% to $104.0 million in 2024, then increased by 5.25% to $109.4 million in 2025.
  • Its Intangibles stands at $109.4 million for Q3 2025, versus $105.6 million for Q2 2025 and $103.8 million for Q1 2025.